Price target
330.690.00 0.00%
The 14 analysts offering 1 year price forecasts for YDO1 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 15 analysts giving stock ratings to YDO1 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
YDO1 EPS for the last quarter is −6.66 CHF despite the estimation of −5.61 CHF. In the next quarter EPS is expected to reach −6.79 CHF. Track more of MADRIGAL PHARMACEU financials and stay on top of what is up with the company.
In the next quarter MADRIGAL PHARMACEU revenue is expected to reach 3.52 M CHF. Check out MADRIGAL PHARMACEU revenue and earnings and make informed decisions.
According to analysts, YDO1 price target is 330.69 CHF with a max estimate of 460.79 CHF and a min estimate of 136.33 CHF. Check if this forecast comes true in a year, meanwhile watch MADRIGAL PHARMACEU stock price chart and keep track of the current situation with YDO1 news and stock market news.
We've gathered opinions of 15 analysts rating YDO1 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.